微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -0.52% | 7.14% | 86.06% | 38/55 | -11.99% | 荣昌生物 | 8.68% | 行业排名> |
| 2025-12-31 | -3.73% | -12.01% | -170.29% | 39/55 | -4.34% | 三生国健 | 39.42% | 行业排名> |
| 2025-09-30 | -1.38% | -64.29% | -7.81% | 37/55 | 1.66% | 特宝生物 | 23.82% | 行业排名> |
| 2025-06-30 | -1.28% | -21.9% | -128.57% | 37/55 | -0.29% | 特宝生物 | 15.74% | 行业排名> |
| 2025-03-31 | -0.56% | -366.67% | 83.18% | 39/55 | -0.09% | 神州细胞 | 36.86% | 行业排名> |
| 2024-12-31 | -3.33% | -909.09% | -296.43% | 39/55 | -1.97% | 特宝生物 | 37.66% | 行业排名> |
| 2024-09-30 | -0.84% | -216.67% | 20% | 38/55 | 2.32% | 特宝生物 | 26.65% | 行业排名> |
| 2024-06-30 | -1.05% | -10400% | -775% | 38/55 | 0.76% | 特宝生物 | 16.5% | 行业排名> |
| 2024-03-31 | -0.12% | -123.53% | 63.64% | 37/55 | 0.71% | 西藏药业 | 8.94% | 行业排名> |
| 2023-12-31 | -0.33% | -103.58% | -145.83% | 35/55 | 1.58% | 特宝生物 | 35.44% | 行业排名> |
| 2023-09-30 | 0.72% | -96.75% | 7300% | 38/55 | 3.57% | 西藏药业 | 25.92% | 行业排名> |
| 2023-06-30 | -0.01% | -100.06% | -101.96% | 39/55 | 48.41% | 智翔金泰 | 2214.89% | 行业排名> |
| 2023-03-31 | 0.51% | 2% | -94.47% | 32/55 | 1.43% | 西藏药业 | 9.54% | 行业排名> |
| 2022-12-31 | 9.22% | -87.69% | -58.32% | 15/55 | -4.57% | 智飞生物 | 35.99% | 行业排名> |
| 2022-09-30 | 22.12% | 2% | 26.91% | 2/55 | 5.99% | 智飞生物 | 27.99% | 行业排名> |
| 2022-06-30 | 17.43% | -58.43% | -76.72% | 3/55 | 1.15% | 智飞生物 | 19.16% | 行业排名> |
| 2021-12-31 | 74.87% | 2% | 78.56% | 3/55 | 15.48% | 通化东宝 | 12.6% | 行业排名> |
| 2021-06-30 | 41.93% | 2% | 2% | 2/55 | 7.96% | 智翔金泰 | 179.38% | 行业排名> |